In this study, we investigated the mechanisms underpinning the sensitivity and resistance of Linsitinib in ESCC, and found an intrinsic Linsitinib resistance mediated through the nuclear factor‐κB (NF‐κB) pathway. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.